Diabetes Technology and Obesity Medicine
This international peer-reviewed open access journal is dedicated to revolutionizing diabetes and obesity management using advanced technologies, innovative therapeutic strategies, and the integration of artificial intelligence (AI). The journal's mission is to equip healthcare professionals with cutting-edge insights into emerging devices, advanced pharmacological treatments, innovative drug delivery systems, and state-of-the-art software solutions, including AI-driven tools related to diabetes and obesity. Each volume of this OA journal explores groundbreaking research and its practical applications in clinical settings, aiming to bridge the gap between scientific discovery and clinical practice. By promoting a multidisciplinary approach and leveraging AI for improved diagnostic accuracy, personalized treatment plans, and enhanced patient monitoring, we aim to redefine excellence in diabetes and obesity care, ultimately improving patient outcomes and quality of life.
The article processing charge (APC) for this journal is $2250 USD.
Diabetes Technology and Obesity Medicine is an international peer-reviewed open access journal dedicated to revolutionizing diabetes and obesity management using advanced technologies, innovative therapeutic strategies, and the integration of artificial intelligence (AI). Our mission is to equip healthcare professionals with cutting-edge insights into emerging devices, advanced pharmacological treatments, innovative drug delivery systems, and state-of-the-art software solutions, including AI-driven tools related to diabetes and obesity. Each volume of this OA journal explores groundbreaking research and its practical applications in clinical settings, aiming to bridge the gap between scientific discovery and clinical practice. By promoting a multidisciplinary approach and leveraging AI for improved diagnostic accuracy, personalized treatment plans, and enhanced patient monitoring, we aim to redefine excellence in diabetes and obesity care, ultimately improving patient outcomes and quality of life.
Diabetes Technology and Obesity Medicine covers the following topics:
Advanced diagnostic and therapeutic tools for diabetes and obesity
Integration of artificial intelligence in patient monitoring and management
Innovative pharmacological treatments and drug delivery systems
Emerging technologies in diabetes care, such as:
Continuous glucose monitoring systems (CGM)
Automatic Insulin Delivery Systems (AID)
Alternate insulin delivery methods
AI-driven predictive analytics for personalized treatment
Breakthrough therapeutic strategies for obesity management
Emerging GLP analogs
Novel drug targets and therapeutics
Behavioral and lifestyle interventions for diabetes and obesity
Telemedicine and remote patient management solutions
Complications associated with diabetes and obesity.
Prevention and management of diabetes-related complications
Cutting-edge software solutions for diabetes and obesity care
Gestational diabetes, pregnancy associated with obesity
Research on new insulins and other medications with rapid onset of action
Strategies for the detection and prevention of hypoglycemia
Pediatric diabetes and obesity care, including specialized treatments and technologies
Audience: Endocrinologists, pediatricians, family practice physicians, nurse practitioners, diabetes clinics, and diabetes equipment manufacturers, among others
Diabetes Technology and Obesity Medicine publishes articles under a CC BY license. This means that articles can be freely redistributed and reused by the author and others as long as the article is properly cited. Published articles in Diabetes Technology and Obesity Medicine can be deposited immediately into an online repository or social network without an embargo. Diabetes Technology and Obesity Medicine articles can be emailed to colleagues, printed, archived in a collection, included in course-packs, and distributed without restrictions. Please read the full Creative Commons license for further information.
| Gitanjali Srivastava, MD, FACP, FAAP | Vanderbilt University School Of Medicine, Brentwood, TN, USA |
| Anna Beth Bradley, MD | Vanderbilt University School of Medicine, Nashville, TN, USA |
| Barbara Gisella Carranza-Leon, MD | Vanderbilt University Medical Center, Nashville, TN, USA |
| Daniel Hsia, MD | Emory University School of Medicine, Atlanta, GA, USA |
| Shivani J Jani, MD | Vanderbilt University, Nashville, TN, USA |
| Weiping Jia, PhD | Shanghai Jiao Tong University School of Medicine, Shanghai, China |
| Dong Wook Kim, MD | Harvard Medical School/Brigham And Womens Hospital, Boston, MA, USA |
| Luiz Guilherme Kraemer-Aguiar, MD, PhD | State University Of Rio De Janeiro, Rio De Janeiro, Brazil |
| Sriram Machineni, MBBS | Fleischer Institute Medical Weight Management Center, Bronx, NY, USA |
| Nasreen Alfaris Md, MPH | King Fahad Medical City, Riyadh |
| Ivania Rizo, MD | Boston Medical Center, Boston, MA, USA |
| Nicolai J Wewer Albrechtsen, MD | Copenhagen University Hospital, Copenhagen, Denmark |
| Michele Yuen, MD | University Of Hong Kong, New Rochelle, NY, USA |